rfhg_116847.1

Basic information about the TSS

---

TSS ID: rfhg_116847.1 Species: human Chr: chr9		Start: 93451744 End: 93451744 Strand: +
Source datasets	EPD
Protocol	TSS_database
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4212623,EH38E2708354)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC098584:-24 GeneID: 23196 HGNC/MGI_ID: HGNC:13247 UniProt_ID: Nearer transcript ids and distances: BC075701:-48 ENST00000277165.11:-59 NM_001286724.2:-59 NM_001286723.2:-59 NM_001286722.2:-59 NM_014612.5:-59 ENST00000375389.7:147 AF214738:147 AF214737:147 BC111736:154 KJ893340:170 KJ898457:170 D80005:191 view more...

Gene_name: family with sequence similarity 120A Gene_symbol: FAM120A Gene_synonyms: KIAA0183 OSSA Gene_source: HGNC:13247

TATA-Box annotation

---

Distance to TSS:	48
Nearest PromoterID:	NM_001286723
Entrez ID:	23196
Nearest Unigene:	Hs.372003
Nearest Refseq:	NM_014612
Nearest Ensembl:	ENSG00000048828
Gene Name:	family with sequence similarity 120A
Gene Alias:	C9orf10|HBVPTPAP|OSSA
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@FAM120A p2@FAM120A p6@FAM120A p7@FAM120A
Sample		p1@FAM120A	p2@FAM120A	p6@FAM120A	p7@FAM120A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	18.31	8.57	0.78	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	16.79	6.07	0.20	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	21.61	5.21	0.19	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	15.59	4.99	0.83	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	17.10	5.40	0.67	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	17.64	5.04	0.00	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	21.79	5.88	0.65	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	18.89	6.06	0.00	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	21.59	4.27	0.00	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	23.19	3.48	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	22.64	5.26	0.40	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	19.92	7.32	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	62.06	17.57	0.97	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	36.84	12.93	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	62.57	16.91	0.22	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	48.54	10.31	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	36.26	13.54	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	37.12	10.12	1.69	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	33.06	5.86	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	40.77	12.49	0.75	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	44.64	15.24	0.67	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	34.52	11.39	0.69	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	47.05	12.54	0.78	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	48.05	17.71	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	48.24	14.45	0.26	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	41.78	16.14	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	39.01	8.79	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	41.02	15.56	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	34.57	8.24	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	34.56	11.94	1.27	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	31.19	9.84	0.63	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	38.29	14.65	0.78	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	36.30	9.07	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	30.35	8.25	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	34.78	10.28	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	41.01	11.88	1.15	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	38.83	9.81	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	37.07	11.48	0.40	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	46.19	17.83	1.35	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	43.69	10.08	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	34.11	12.70	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	30.30	9.37	0.29	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	45.34	13.08	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	46.68	12.41	0.87	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	57.22	15.06	1.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	43.97	13.96	0.47	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	44.38	12.95	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	48.58	14.90	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	44.04	11.25	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	39.83	11.93	0.61	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	46.52	10.04	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	52.70	12.23	0.89	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	55.97	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	35.13	8.16	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	25.19	7.62	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	52.85	20.13	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	43.17	11.02	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	33.06	11.02	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	29.55	8.03	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	37.09	9.43	0.63	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	22.56	7.05	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	20.19	3.93	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	130.57	21.50	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	45.19	9.17	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	36.72	5.85	0.65	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	31.59	5.32	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	64.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	94.77	31.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	21.94	5.85	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	22.31	4.46	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	18.30	8.44	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	45.70	8.28	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	29.39	6.19	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	30.57	5.20	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	33.58	10.29	0.79	0.16
Adipocyte - breast, donor2	11327-117E4	40.43	11.55	0.64	0.32
Adipocyte - omental, donor1	11473-119C6	37.15	10.56	0.89	0.38
Adipocyte - omental, donor2	11474-119C7	20.93	5.98	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	24.45	9.04	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	20.42	6.38	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	3.30	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	26.65	6.77	2.26	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	36.15	10.43	1.56	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	44.20	19.56	1.17	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	35.00	13.13	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	37.63	17.84	1.12	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	33.51	22.92	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	41.99	18.10	1.13	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	30.34	9.36	1.29	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	17.60	9.06	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	27.82	14.47	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	32.02	12.48	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	21.85	7.53	0.50	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	26.18	12.44	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	26.49	6.39	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	35.80	9.06	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	23.31	11.47	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	23.96	3.59	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	28.25	15.83	0.18	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	15.06	20.08	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	25.89	10.27	0.41	0.41
Anulus Pulposus Cell, donor1	11248-116E6	29.18	10.64	0.23	0.80
Anulus Pulposus Cell, donor2	11463-119B5	32.08	11.27	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	10.78	5.84	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	15.63	10.85	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	6.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	11.06	7.17	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	10.12	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.26	3.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	14.29	7.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	11.17	7.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.66	6.53	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.43	6.78	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	17.42	5.81	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	6.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	21.09	7.91	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	9.55	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	9.95	2.11	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	9.11	6.43	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	21.73	9.45	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	16.57	4.01	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	6.83	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	19.41	6.30	0.50	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	4.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	10.62	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	18.87	6.52	0.34	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	8.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.22	5.83	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.59	9.11	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	4.85	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.41	4.56	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.75	8.34	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	15.23	5.42	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	11.73	5.16	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.65	7.40	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	12.13	4.99	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	10.53	8.77	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	12.95	6.02	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	16.63	7.13	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.73	6.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	13.24	5.35	0.00	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.90	4.45	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	15.54	5.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.30	4.87	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	12.47	4.06	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	12.28	6.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.94	6.27	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	4.63	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	15.44	4.93	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	13.24	5.41	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	12.39	3.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	16.78	8.05	0.46	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.19	2.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.72	8.26	0.62	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.08	4.59	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	12.43	8.60	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	20.84	5.77	0.00	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	6.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.42	4.98	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	15.89	6.88	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	10.18	4.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	27.39	15.84	0.49	0.86
Astrocyte - cerebellum, donor2	11580-120F5	39.71	13.52	0.34	0.17
Astrocyte - cerebellum, donor3	11661-122F5	25.80	9.86	0.21	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	26.84	12.20	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	52.41	19.74	0.32	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	45.49	18.20	0.89	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	101.27	14.79	0.69	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	107.74	22.93	0.38	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	103.44	18.89	0.57	0.57
Basophils, donor1	12241-129G9	37.40	9.42	0.00	0.00
Basophils, donor2	12242-129H1	31.39	16.60	0.36	0.00
Basophils, donor3	12243-129H2	53.80	21.02	0.59	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	31.91	9.27	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	21.49	4.11	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.06	6.90	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	29.53	8.94	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	32.70	13.13	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	35.99	5.76	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	62.04	17.21	0.93	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	66.14	18.40	0.23	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	23.66	22.06	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	51.71	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	49.03	13.53	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	65.89	24.50	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	62.35	23.93	0.00	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	46.99	14.15	0.85	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	68.61	15.54	1.52	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	76.27	16.77	2.96	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	56.95	18.94	1.30	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	38.02	11.77	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	54.49	16.11	0.71	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	27.96	6.70	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	23.74	5.80	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	20.33	5.45	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	28.98	5.87	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	24.21	5.34	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.98	6.96	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	22.24	5.85	0.70	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	27.46	11.09	2.11	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	26.62	8.87	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	39.72	11.90	1.64	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	24.15	6.78	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	16.45	6.66	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	30.89	8.92	0.92	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	19.91	6.33	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	25.31	9.17	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	44.38	13.18	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	37.51	10.82	0.70	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	37.45	10.52	1.26	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	20.94	3.86	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	18.32	6.69	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	14.92	5.70	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	28.42	6.97	0.70	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	31.96	5.58	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	20.91	5.39	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	27.03	11.06	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	13.68	2.32	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	16.01	3.48	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	29.86	8.72	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	41.81	12.94	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	29.89	13.86	0.65	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	59.33	26.78	0.47	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	43.14	18.16	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	56.41	26.53	0.67	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	34.19	13.01	0.26	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	37.98	14.27	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	28.63	11.37	0.42	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	24.39	8.13	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	33.22	12.20	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	41.42	8.28	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	43.18	17.06	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	37.52	12.33	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	33.69	12.63	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	31.37	15.69	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	22.41	18.46	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	46.03	27.12	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	39.17	12.33	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	48.97	22.72	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	44.45	12.93	0.40	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	28.36	9.19	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	7.03	7.03	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	7.87	5.62	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	28.93	17.28	0.00	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	29.54	17.59	0.68	0.68
CD4+ T Cells, donor1	11225-116C1	38.21	25.71	1.07	0.71
CD4+ T Cells, donor2	11306-117C1	55.11	33.68	3.06	0.61
CD4+ T Cells, donor3	11382-118B5	46.36	29.28	2.13	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	47.98	27.06	1.28	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	54.35	26.73	0.67	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	57.78	27.31	0.86	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	23.23	22.28	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	23.88	26.69	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	9.89	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	47.69	31.94	1.30	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	79.48	34.40	0.85	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	71.74	29.02	0.64	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	24.21	10.76	0.00	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	28.30	18.17	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	40.04	20.24	0.44	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	33.31	29.94	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	64.41	21.40	0.83	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	49.12	27.40	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	44.33	22.84	0.54	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	40.73	20.37	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	39.45	21.52	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	48.03	31.89	1.30	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	38.12	25.56	1.08	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	51.28	32.99	0.84	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	26.29	22.25	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	27.73	22.96	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	37.04	20.92	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	37.12	22.76	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	30.47	12.00	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	25.12	15.35	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	39.32	21.88	1.11	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	30.43	25.03	0.49	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	60.06	10.78	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	48.70	26.86	1.79	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	48.47	18.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	40.27	31.43	0.33	1.64
CD8+ T Cells, donor2	11307-117C2	45.05	29.28	1.13	0.00
CD8+ T Cells, donor3	11383-118B6	52.01	33.08	2.02	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	24.32	11.24	0.46	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	26.36	9.59	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	21.89	11.76	0.55	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	17.11	9.01	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	20.64	11.04	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	19.78	8.19	0.23	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	25.86	13.25	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	27.64	9.21	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	21.81	11.96	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	27.17	9.06	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	24.98	9.88	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	26.38	12.26	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	28.45	8.76	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	31.42	5.47	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	36.55	6.71	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	23.05	7.56	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	25.03	7.77	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	30.17	10.84	0.24	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	27.25	11.73	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	24.61	12.30	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	22.12	8.34	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	26.01	9.56	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	21.68	5.91	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	27.23	9.08	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	26.50	8.83	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	28.68	6.29	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	38.07	8.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	73.11	36.55	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	26.68	7.41	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	25.36	10.94	0.11	0.32
Chondrocyte - de diff, donor1	11261-116G1	19.41	14.91	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	24.52	11.73	0.71	0.71
Chondrocyte - de diff, donor3	11410-118E6	36.98	14.56	0.68	0.11
Chondrocyte - re diff, donor2	11339-117F7	25.07	10.74	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	45.70	8.49	0.81	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	35.12	13.66	0.46	1.26
Ciliary Epithelial Cells, donor2	11323-117D9	41.26	7.48	0.21	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	43.10	12.21	0.18	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	36.41	15.59	0.37	1.10
Corneal Epithelial Cells, donor1	11526-119I5	43.48	8.78	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	42.09	11.38	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	40.13	11.76	0.26	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	35.66	12.22	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	35.64	15.46	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	13.80	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	42.01	13.82	0.11	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	34.85	12.30	1.37	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	20.24	7.83	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	22.75	12.58	0.48	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	27.02	11.34	0.67	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	30.51	3.52	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	37.61	10.46	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	40.50	12.58	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	41.01	9.60	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	51.06	15.53	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	45.05	12.10	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	30.81	3.77	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	34.08	6.69	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	32.14	5.07	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	17.23	5.65	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	20.83	6.25	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	28.64	7.23	0.71	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	31.21	13.60	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	31.97	9.43	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	59.02	22.12	0.75	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	67.57	17.82	0.43	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	97.58	18.93	0.49	0.49
Endothelial Cells - Vein, donor1	11267-116G7	27.30	14.79	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	39.81	4.19	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	38.78	10.52	0.16	0.16
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	85.81	11.55	0.00	0.00
Eosinophils, donor3	12246-129H5	74.90	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	36.65	9.04	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	10.40	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	32.54	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	32.84	8.62	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	17.96	3.83	0.55	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	30.77	7.37	0.54	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	32.38	11.28	1.09	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	38.62	12.96	0.14	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	48.62	14.13	1.05	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	21.61	22.40	0.79	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	50.49	22.92	1.00	0.66
Fibroblast - Cardiac, donor1	11268-116G8	28.58	16.33	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	20.46	11.37	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	21.29	7.73	0.32	0.47
Fibroblast - Cardiac, donor4	11452-119A3	50.62	15.46	0.91	0.91
Fibroblast - Cardiac, donor5	11456-119A7	34.14	12.69	0.38	0.76
Fibroblast - Cardiac, donor6	11460-119B2	40.32	13.34	0.76	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	25.86	16.21	0.94	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	26.75	12.51	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	54.20	10.25	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	64.12	20.07	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	40.54	18.83	1.02	0.51
Fibroblast - Dermal, donor1	11269-116G9	46.25	13.15	0.94	0.23
Fibroblast - Dermal, donor2	11346-117G5	25.00	6.13	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	47.87	15.96	1.09	0.36
Fibroblast - Dermal, donor4	11450-119A1	53.58	14.36	0.11	0.45
Fibroblast - Dermal, donor5	11454-119A5	48.85	15.88	0.52	0.00
Fibroblast - Dermal, donor6	11458-119A9	51.81	14.78	0.32	0.49
Fibroblast - Gingival, donor1	11237-116D4	58.93	15.20	0.62	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	55.28	26.72	1.57	0.52
Fibroblast - Gingival, donor2	11318-117D4	47.05	15.42	0.13	0.40
Fibroblast - Gingival, donor3	11394-118C8	88.95	23.40	1.26	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	52.98	20.78	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	48.63	22.38	1.76	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	57.99	21.36	0.78	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	37.32	18.26	0.81	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	115.04	51.52	4.94	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	39.78	14.33	0.58	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	40.09	12.54	0.27	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	40.37	16.23	1.10	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	47.25	25.53	1.47	1.17
Fibroblast - Lung, donor1	11270-116H1	14.95	6.80	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	46.26	5.97	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	42.84	12.66	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	53.31	27.49	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	47.55	15.38	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	32.47	13.15	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	86.07	32.48	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	31.95	7.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	41.69	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	45.58	10.86	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	87.67	21.69	0.91	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	66.40	22.34	0.31	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	37.40	19.46	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	45.36	20.79	0.81	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	49.98	17.28	1.39	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	28.19	9.28	0.33	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	68.07	20.32	1.42	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	34.75	14.03	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	28.07	7.12	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	29.37	21.63	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	28.24	12.97	0.18	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	42.77	15.77	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	29.18	13.24	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	31.95	14.03	0.43	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	27.08	18.22	0.00	0.51
Fibroblast - skin normal, donor1	11553-120C5	35.44	17.56	0.98	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	32.28	18.05	0.60	0.20
Fibroblast - skin normal, donor2	11561-120D4	27.93	17.48	0.50	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	31.73	19.95	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	41.34	13.75	0.41	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	27.35	13.68	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.36	15.44	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	29.61	15.87	0.53	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	35.93	12.48	0.17	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	30.74	6.43	0.94	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	47.06	24.40	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	28.43	9.53	0.52	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	48.93	12.23	0.78	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	41.65	12.78	0.77	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	8.42	6.12	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	10.85	5.10	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	29.95	8.56	0.00	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	23.44	5.79	1.10	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	22.38	18.95	1.14	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	32.30	9.31	0.40	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	22.73	10.31	1.59	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	22.83	10.76	0.00	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	34.49	3.54	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	18.09	4.80	0.14	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	23.27	4.31	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	16.92	3.49	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	16.35	2.97	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	18.13	2.49	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	16.67	6.10	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	19.17	4.11	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	19.43	2.87	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	20.33	4.15	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	15.96	6.80	0.30	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	15.10	5.09	0.16	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	18.54	5.59	0.45	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	19.56	7.06	0.00	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	16.12	3.73	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	27.04	8.78	0.44	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.29	7.60	0.62	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.57	6.49	0.51	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	19.36	5.75	0.33	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.97	6.91	0.50	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	15.93	4.08	0.82	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	15.27	4.95	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.41	5.19	0.46	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	20.18	7.84	0.33	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	17.63	7.72	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	23.00	5.66	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	20.75	8.59	0.16	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	20.53	3.85	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	21.98	5.12	0.38	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	18.19	7.12	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	16.12	8.51	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	18.92	5.75	0.31	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	24.37	5.93	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	21.88	7.01	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	20.46	8.24	0.65	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	16.58	10.16	0.27	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.04	9.64	0.61	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	21.11	7.38	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.29	8.40	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	20.28	9.59	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	25.88	8.55	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	34.71	14.88	0.99	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	28.23	9.63	0.53	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	29.25	7.67	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	14.74	6.61	0.51	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	13.74	5.77	0.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	24.50	6.01	0.00	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	27.00	7.98	0.20	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	8.45	2.50	0.31	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	6.50	3.11	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	9.69	5.07	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	4.95	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	17.41	4.64	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	9.63	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	10.43	5.22	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	12.37	4.23	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	14.00	6.59	0.41	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	13.70	5.31	0.56	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	9.48	5.88	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	15.10	4.19	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	12.72	7.32	1.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	9.85	4.42	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	6.26	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	15.46	2.86	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	8.88	3.26	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	5.08	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	9.11	5.80	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	9.44	7.59	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	9.23	3.84	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	9.78	3.91	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	15.38	6.02	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	11.17	4.62	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	16.77	7.53	0.34	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	13.68	4.25	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	12.67	3.02	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	17.29	3.05	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	11.57	6.78	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	5.92	2.47	0.49	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	15.35	5.90	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	11.67	2.92	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	11.41	3.07	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	11.02	7.63	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	8.95	3.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	8.25	3.88	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	27.39	13.70	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	42.41	15.39	1.66	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	48.35	13.49	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	21.25	17.13	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	21.30	10.86	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	34.46	10.79	0.35	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	34.27	11.31	0.34	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	32.99	9.10	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	34.10	13.55	0.55	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	30.95	10.96	0.21	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	32.51	12.06	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	28.02	8.84	0.62	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	20.93	6.86	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	25.31	8.65	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	52.60	14.55	0.56	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	38.52	12.12	0.43	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	7.93	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	44.44	15.87	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	30.51	10.17	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	24.48	10.14	0.17	0.17
Hepatocyte, donor1	11523-119I2	42.37	31.48	0.00	0.00
Hepatocyte, donor2	11603-120I1	37.71	22.62	1.08	0.00
Hepatocyte, donor3	11684-122I1	69.33	27.00	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	64.62	38.51	1.31	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	14.68	6.82	0.00	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	28.40	9.88	0.27	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	9.55	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	30.46	2.77	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	35.60	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	46.13	25.63	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	37.36	16.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	18.34	10.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	10.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	29.12	11.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	23.28	7.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	20.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	37.16	8.19	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	32.48	7.73	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	35.53	13.57	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	64.40	8.05	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	40.74	13.85	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	31.91	13.01	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	28.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	33.75	12.06	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	16.62	7.39	0.92	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	18.88	4.72	0.00	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	20.86	9.98	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	33.36	9.69	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	33.03	6.35	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	41.45	15.94	0.64	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	30.99	9.11	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	42.13	9.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	16.59	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	25.31	8.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	47.41	8.78	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	12.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	45.90	11.82	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	46.47	19.92	0.00	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	59.29	9.59	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	47.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	46.94	6.40	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	40.18	6.93	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	48.44	8.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	57.07	9.20	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	18.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	34.89	4.23	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	39.74	10.85	0.33	0.16
Keratinocyte - epidermal, donor2	11349-117G8	24.01	5.27	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	42.31	10.03	0.19	0.09
Keratinocyte - oral, donor1	11251-116E9	66.52	20.66	0.23	0.11
Keratocytes, donor1	11527-119I6	51.92	10.31	0.00	0.00
Keratocytes, donor2	11607-120I5	37.50	11.72	1.17	0.00
Keratocytes, donor3	11688-122I5	43.27	9.09	0.40	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	46.16	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	25.89	10.79	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	24.34	5.77	0.23	0.23
Lens Epithelial Cells, donor3	11690-122I7	26.03	10.09	0.20	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	25.02	7.47	0.24	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	19.54	4.74	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	26.45	7.08	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	11.29	3.76	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	25.84	8.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	14.12	5.82	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	16.42	5.75	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	15.17	4.30	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	20.83	7.04	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.19	3.96	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	24.24	6.01	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	11.85	2.78	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	16.38	4.18	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	22.42	4.05	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	15.25	4.94	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.09	8.93	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	14.34	3.43	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	19.58	4.57	0.18	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	15.47	5.27	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	15.82	4.98	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	15.18	4.48	0.00	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	16.49	3.39	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	17.50	5.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	17.41	4.24	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.41	4.67	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	23.24	8.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	16.84	5.56	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	19.26	3.44	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	19.00	4.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	14.53	4.88	0.11	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	12.11	2.91	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.88	3.97	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	15.49	5.45	0.00	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	30.36	4.81	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	15.81	4.69	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.77	4.26	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	17.69	4.50	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	26.78	5.17	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	20.30	4.76	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	14.22	2.84	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	17.94	4.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	13.07	4.51	0.31	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	14.68	3.58	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	15.68	2.29	0.33	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.65	4.47	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	29.21	7.18	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	16.90	4.61	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	11.64	3.88	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	29.46	24.93	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	56.00	19.95	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	42.31	14.10	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	53.74	16.08	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	34.46	18.99	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	35.49	8.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.22	10.31	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	51.15	10.71	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	39.13	17.87	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	48.57	16.29	0.87	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	45.47	18.91	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	59.21	23.17	0.27	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	47.24	16.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	45.87	21.52	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	29.98	20.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	50.43	19.36	0.00	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	50.69	17.61	0.53	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	54.79	20.41	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	45.40	19.63	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	65.23	27.72	1.63	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	63.72	20.82	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	51.01	17.66	0.00	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	76.25	22.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	62.42	22.64	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	52.01	21.52	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	46.47	21.02	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	53.38	25.45	1.06	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	44.99	18.81	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	32.24	19.57	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	54.49	16.12	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	45.29	9.62	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	34.46	18.87	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	44.74	23.50	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	54.58	14.36	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	53.78	23.15	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	62.43	19.69	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	48.24	13.78	0.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	53.95	21.41	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	61.30	21.99	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	54.30	10.86	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	41.95	21.33	1.42	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	61.87	18.90	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	54.75	11.27	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	46.46	16.16	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	60.38	21.11	1.11	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	53.49	13.96	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	41.25	10.58	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	54.02	26.41	0.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	39.98	14.54	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	65.92	16.86	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	51.30	20.72	0.49	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	42.34	10.35	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	56.82	22.12	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	46.41	20.28	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	46.47	24.10	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	52.11	16.92	1.34	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	50.44	21.51	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	42.88	16.49	0.66	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	56.04	19.72	0.00	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	56.01	17.07	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	52.00	12.86	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	50.35	18.99	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	48.60	14.66	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	43.55	15.19	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	69.21	24.51	1.44	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	48.90	25.44	1.19	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	41.93	18.23	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	25.59	9.68	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	66.12	24.70	0.76	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	47.51	16.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	24.19	11.49	0.00	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	54.51	25.35	0.63	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	51.71	18.13	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	31.61	15.52	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	52.45	16.97	0.51	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	55.17	13.44	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	25.54	12.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	47.84	23.71	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	48.55	12.53	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	31.32	12.11	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	49.25	17.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	44.83	10.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	34.75	17.11	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	54.15	16.57	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	41.30	13.77	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	29.34	23.12	0.89	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	57.56	17.10	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	56.75	20.71	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	36.66	18.60	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	55.68	19.15	1.34	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	55.89	22.62	0.52	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	33.82	21.22	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	74.83	18.71	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	34.42	7.75	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	51.93	10.83	0.37	0.37
Macrophage - monocyte derived, donor3	11389-118C3	57.81	11.80	0.39	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	22.83	5.84	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	27.25	7.76	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	29.19	7.51	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	43.34	10.76	0.20	0.30
Mammary Epithelial Cell, donor2	11350-117G9	37.93	10.71	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	33.42	8.73	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	17.63	5.42	0.68	1.36
Mast cell, donor1	11563-120D6	64.67	18.71	2.05	1.62
Mast cell, donor2	11565-120D8	38.04	16.94	3.27	2.08
Mast cell, donor3	11566-120D9	52.68	18.01	4.28	0.90
Mast cell, donor4	11567-120E1	48.05	20.57	5.14	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	72.19	21.74	1.55	0.67
Mast cell, expanded and stimulated, donor8	11942-126A7	52.53	17.51	1.75	0.58
Mast cell, expanded, donor5	11939-126A4	52.89	14.34	1.72	0.34
Mast cell, expanded, donor8	11941-126A6	88.54	27.78	4.52	0.67
Melanocyte - dark, donor1	11502-119F8	38.61	9.75	0.60	0.50
Melanocyte - dark, donor2	11582-120F7	29.42	9.00	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	29.27	18.91	0.29	0.22
Melanocyte - light, donor1	11274-116H5	26.56	13.16	1.41	0.00
Melanocyte - light, donor2	11351-117H1	26.62	10.92	0.68	0.68
Melanocyte - light, donor3	11423-118G1	39.03	15.61	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	37.69	12.39	0.31	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	20.71	13.72	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	39.64	8.04	0.54	0.80
Meningeal Cells, donor1	11493-119E8	34.49	22.95	0.25	0.50
Meningeal Cells, donor2	11573-120E7	40.05	17.61	0.00	0.88
Meningeal Cells, donor3	11654-122E7	42.14	18.58	0.57	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	35.93	7.98	1.14	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	21.64	7.45	0.10	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	14.46	14.46	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	34.01	14.39	1.31	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	56.69	7.89	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	33.25	8.68	0.21	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	35.69	13.07	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	38.46	11.43	0.00	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	37.26	13.88	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	34.37	11.46	0.00	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	16.34	9.56	0.28	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	42.00	10.04	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	46.05	13.95	0.53	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	21.66	10.39	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	46.11	16.65	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	39.70	14.53	1.06	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	35.34	10.95	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	36.28	7.98	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	36.33	9.81	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	27.53	15.51	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	44.23	12.36	0.43	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	25.66	6.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	38.17	8.62	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	34.16	12.96	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	22.63	3.10	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	30.29	6.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	25.48	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	32.03	8.51	0.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	26.07	9.78	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	34.34	7.93	0.20	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	26.53	7.13	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	13.27	8.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.77	4.94	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	13.16	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	21.43	5.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	21.18	3.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	23.25	4.17	0.30	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	3.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	23.84	4.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	26.14	7.13	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	17.14	3.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	17.73	4.60	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	17.46	7.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	26.50	5.30	0.61	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	17.16	5.15	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	23.12	7.34	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	19.27	3.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	20.28	4.56	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	6.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	22.02	5.44	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	26.76	5.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	13.08	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.51	5.29	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.81	6.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	19.02	2.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	22.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	16.20	3.94	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	19.87	5.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	29.46	7.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	20.58	5.95	0.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.70	3.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	33.15	6.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	26.32	5.13	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	20.13	3.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	34.44	5.68	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	20.48	3.93	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	19.53	5.40	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	32.05	4.66	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	30.17	8.75	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	23.79	6.26	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	26.78	8.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	19.35	4.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	29.02	3.73	0.28	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	23.06	5.44	0.26	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	26.60	5.15	0.00	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	30.49	5.08	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	20.55	6.94	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	31.73	6.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	20.76	4.94	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	17.84	7.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	28.97	6.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	31.85	5.31	0.00	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	21.02	4.55	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	40.80	6.64	0.25	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	31.28	4.56	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	21.46	4.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	30.27	6.05	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	34.21	2.89	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	20.25	4.76	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	7.13	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	35.49	5.26	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	16.83	4.21	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	18.19	4.94	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.94	8.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	16.90	4.51	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	25.30	6.39	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	18.44	5.43	0.45	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	16.21	2.95	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	24.92	3.30	0.37	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	35.78	4.67	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	9.09	2.14	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	24.24	11.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	24.03	4.22	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	2.72	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	7.55	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.02	9.69	0.00	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	30.31	9.41	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	30.04	4.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	41.74	7.93	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	123.59	19.58	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	39.90	6.38	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	21.76	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	159.87	33.08	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	25.11	5.02	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	39.75	9.30	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	31.35	6.49	0.27	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	24.39	5.68	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	44.54	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	21.34	4.47	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	33.29	5.41	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	21.08	2.95	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	58.14	8.17	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	29.34	5.47	0.36	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	26.52	3.71	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	21.01	3.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	109.94	12.80	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	28.46	7.16	0.00	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	37.04	7.58	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	19.69	2.81	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	26.66	3.68	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	27.96	6.11	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	110.36	17.93	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	432.36	78.38	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	30.74	7.57	0.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	24.98	3.81	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	37.98	8.07	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	22.75	5.58	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	33.99	3.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	30.21	5.41	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	26.59	3.97	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	22.29	5.57	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	27.24	3.03	0.00	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	27.37	4.56	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	32.25	5.67	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	35.73	5.43	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.05	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	23.93	5.32	0.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	27.78	3.47	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	32.54	7.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	40.83	5.14	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	31.61	6.19	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	23.72	8.13	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	127.74	51.10	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.90	5.49	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	26.75	5.98	0.31	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	59.32	7.87	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	23.73	1.58	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	139.44	19.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	96.10	30.35	0.00	0.00
Myoblast, donor1	11241-116D8	33.67	12.05	0.62	0.12
Myoblast, donor2	11322-117D8	52.74	20.52	0.38	0.19
Myoblast, donor3	11398-118D3	38.34	14.46	1.01	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	55.31	21.31	0.29	0.73
Natural Killer Cells, donor1	11230-116C6	38.13	24.29	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	51.57	28.95	0.90	0.30
Natural Killer Cells, donor3	11387-118C1	54.66	27.06	0.92	0.55
Neural stem cells, donor1	11275-116H6	42.83	21.41	0.73	1.09
Neural stem cells, donor2	11352-117H2	23.11	9.63	0.00	1.93
Neurons, donor1	11494-119E9	14.79	15.93	1.14	1.14
Neurons, donor2	11574-120E8	16.73	4.40	0.44	0.44
Neurons, donor3	11655-122E8	17.27	3.29	0.00	2.47
Neutrophils, donor1	11233-116C9	68.67	5.57	5.57	0.00
Neutrophils, donor2	11314-117C9	95.66	11.60	11.60	2.90
Neutrophils, donor3	11390-118C4	130.72	15.88	10.38	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	37.76	18.52	0.59	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	33.86	8.79	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	19.05	10.23	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	34.96	8.53	0.14	0.28
Olfactory epithelial cells, donor2	11934-125I8	38.65	11.43	0.29	0.14
Olfactory epithelial cells, donor3	11935-125I9	33.60	9.53	0.00	0.23
Olfactory epithelial cells, donor4	11936-126A1	46.46	10.71	0.29	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	44.53	12.64	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	22.33	13.40	1.28	0.00
Osteoblast - differentiated, donor2	11353-117H3	21.72	3.43	4.57	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.24	14.28	0.62	0.00
Osteoblast, donor1	11277-116H8	15.44	9.19	1.17	0.00
Osteoblast, donor2	11354-117H4	44.25	16.86	0.00	0.00
Osteoblast, donor3	11426-118G4	35.90	16.17	0.71	0.89
Pancreatic stromal cells, donor1	11249-116E7	38.83	12.05	1.10	0.76
Pericytes, donor1	11491-119E6	15.47	10.68	0.56	0.33
Pericytes, donor2	11571-120E5	17.88	10.19	0.68	0.91
Pericytes, donor3	11652-122E5	39.88	9.77	0.20	0.20
Perineurial Cells, donor1	11499-119F5	37.07	12.32	0.11	0.57
Perineurial Cells, donor2	11579-120F4	38.18	14.26	0.28	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	67.89	29.64	0.64	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	56.81	32.57	1.22	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	75.71	30.54	1.42	0.26
Placental Epithelial Cells, donor1	11278-116H9	13.39	4.07	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	15.52	9.98	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	12.37	7.26	0.59	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	27.21	6.65	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	27.95	13.32	0.94	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	34.46	12.01	0.65	0.26
Preadipocyte - breast, donor2	11328-117E5	37.60	12.38	0.45	0.45
Preadipocyte - omental, donor1	11468-119C1	31.65	11.83	0.96	1.07
Preadipocyte - omental, donor2	11329-117E6	39.72	7.42	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	45.55	15.18	0.29	0.72
Preadipocyte - perirenal, donor1	11469-119C2	19.69	7.87	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	29.48	11.36	0.92	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	59.32	20.90	0.53	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	39.00	19.58	1.19	0.34
Preadipocyte - visceral, donor1	11280-116I2	51.14	21.80	1.12	0.75
Preadipocyte - visceral, donor2	11357-117H7	50.16	17.03	1.38	1.38
Preadipocyte - visceral, donor3	11429-118G7	34.17	15.78	0.73	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	10.41	3.77	0.91	0.75
Prostate Epithelial Cells, donor2	11331-117E8	40.76	7.85	1.90	0.54
Prostate Epithelial Cells, donor3	11404-118D9	60.87	8.57	1.16	0.55
Prostate Stromal Cells, donor1	11254-116F3	38.84	11.39	0.68	0.68
Prostate Stromal Cells, donor2	11332-117E9	49.85	13.27	0.36	0.54
Prostate Stromal Cells, donor3	11405-118E1	42.54	9.49	1.88	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	43.07	9.85	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	37.71	8.04	0.28	0.28
Renal Epithelial Cells, donor1	11517-119H5	28.40	12.17	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	29.16	8.54	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	43.09	10.16	0.11	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	31.32	11.57	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	34.10	14.15	0.40	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	54.39	18.43	0.44	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	26.62	2.66	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	37.64	9.02	0.00	0.44
Renal Mesangial Cells, donor2	11598-120H5	50.16	13.17	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	31.35	8.60	0.00	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	66.84	15.57	0.27	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	35.84	13.49	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	44.16	12.34	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	35.78	8.82	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	23.59	13.64	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	31.90	4.12	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	18.57	7.53	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	70.29	23.25	2.94	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	42.88	6.25	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	17.61	5.50	3.30	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	19.14	7.54	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	26.27	6.76	0.00	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	71.90	9.24	0.40	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	58.78	9.59	0.11	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	51.11	9.18	0.87	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	70.16	12.47	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	77.89	9.94	0.92	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	44.91	9.72	0.27	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	55.82	10.59	0.30	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	61.28	7.88	0.18	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	41.32	11.33	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	64.39	10.84	0.43	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	78.33	9.51	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	40.53	9.56	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	76.58	11.46	0.47	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	55.62	9.58	1.32	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	47.91	8.36	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	59.28	9.25	0.78	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	65.50	10.88	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	40.58	11.21	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	59.14	10.09	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	68.02	7.86	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	49.23	10.39	0.55	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	66.47	10.42	0.74	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	65.15	12.22	0.27	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	31.84	13.92	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	67.66	11.31	0.79	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	65.71	9.59	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	39.60	9.12	0.83	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	66.36	13.27	0.22	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	64.96	9.40	0.84	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	50.47	12.92	0.81	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	64.71	10.39	0.51	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	70.56	11.37	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	42.30	11.35	0.52	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	63.10	10.56	0.27	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	74.04	10.18	0.99	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	48.74	10.74	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	69.54	13.32	1.48	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	76.77	9.06	1.87	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	40.10	10.65	1.24	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	65.48	14.76	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	96.74	10.88	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	34.75	8.00	0.28	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	68.82	13.97	3.49	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	49.26	10.88	1.21	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	34.02	9.55	1.71	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	77.29	17.47	1.31	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	64.49	7.30	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	35.26	11.45	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	69.44	11.08	4.75	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	70.09	10.48	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	22.32	9.21	2.48	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	50.80	13.66	9.82	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	52.89	7.21	1.80	1.20
Schwann Cells, donor1	11498-119F4	32.91	14.29	0.56	0.38
Schwann Cells, donor2	11578-120F3	20.41	6.80	0.00	0.00
Schwann Cells, donor3	11659-122F3	23.00	12.05	0.66	0.44
Sebocyte, donor1	11220-116B5	55.87	18.08	1.10	0.55
Sebocyte, donor2	11301-117B5	45.50	6.89	0.46	0.46
Sebocyte, donor3	11378-118B1	33.18	13.19	0.00	0.00
Sertoli Cells, donor1	11255-116F4	74.55	28.16	3.31	0.00
Sertoli Cells, donor2	11333-117F1	59.31	25.42	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	33.61	17.07	0.88	0.79
Skeletal Muscle Cells, donor2	11358-117H8	22.41	2.89	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	31.77	9.20	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	41.32	16.34	0.31	0.63
Skeletal Muscle Cells, donor5	11455-119A6	42.07	13.97	0.45	0.74
Skeletal Muscle Cells, donor6	11459-119B1	38.94	11.08	0.62	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	47.76	19.40	0.76	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	60.50	15.12	0.29	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	64.98	19.25	0.50	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	32.44	12.22	0.59	1.01
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	29.67	6.51	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	13.76	6.19	0.28	0.28
Skin - palm, donor1	10286-104F7	16.12	13.43	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	25.80	5.62	0.43	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	44.17	9.81	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	29.34	9.22	0.39	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	43.79	9.31	1.11	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	62.45	19.55	1.13	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	75.91	32.77	1.27	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	101.78	20.76	0.90	0.75
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	25.61	12.34	0.62	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	15.34	12.45	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	39.97	10.58	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	26.96	15.69	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	22.05	11.81	1.18	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	30.13	14.68	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	23.02	16.01	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	36.73	14.77	0.80	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	32.14	13.52	0.44	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	22.92	7.17	0.90	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.65	11.07	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	30.12	7.38	0.30	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	37.30	8.54	0.85	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	36.11	12.85	0.33	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	43.84	13.40	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	32.33	17.68	0.51	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	36.72	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.03	8.58	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	32.00	9.14	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	45.63	12.05	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	46.39	10.29	0.42	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	25.21	10.83	1.24	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	23.71	3.23	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	33.17	6.28	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	45.41	10.58	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	55.83	14.37	0.16	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	43.28	19.22	2.01	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	46.88	15.70	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	15.10	10.87	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	60.67	16.16	0.26	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	29.56	11.45	1.07	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	51.72	14.15	1.75	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	16.74	9.39	0.25	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	44.93	18.09	1.51	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	29.26	16.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	33.60	99.50	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	33.02	16.74	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	34.33	13.63	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	36.04	14.42	1.57	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	29.79	7.08	0.88	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	33.32	12.91	0.08	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	38.77	7.94	0.47	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	27.92	8.78	0.86	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	37.73	9.94	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	23.13	12.03	0.19	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	38.01	11.88	0.28	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.82	12.57	0.25	0.67
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	18.09	4.76	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	30.09	11.50	0.49	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	25.63	15.02	0.00	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	20.19	5.27	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	39.26	10.69	0.39	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	18.78	5.02	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	11.16	2.98	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.20	6.11	0.72	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	26.69	5.39	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	21.66	7.88	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	19.30	6.35	2.03	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	27.95	12.78	2.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	28.42	6.27	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	21.54	8.71	0.00	0.00
Synoviocyte, donor1	11291-117A4	25.08	11.11	0.17	0.67
Synoviocyte, donor2	11368-117I9	39.73	13.58	0.34	0.84
Synoviocyte, donor3	11440-118H9	26.59	16.31	0.22	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	48.24	14.65	1.07	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	45.59	7.93	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	33.11	16.21	0.46	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	35.41	7.81	0.50	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	40.20	8.89	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	35.51	9.16	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	68.89	21.41	2.83	0.98
Urethra, donor2	10319-105A4	86.32	23.38	0.00	1.80
Urothelial Cells, donor1	11520-119H8	28.69	7.17	0.27	0.27
Urothelial Cells, donor2	11600-120H7	28.84	5.61	0.00	0.00
Urothelial Cells, donor3	11681-122H7	36.21	11.00	0.46	0.00
Urothelial cells, donor0	11216-116B1	52.16	13.15	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	51.61	16.02	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	41.46	22.87	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	82.83	15.74	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	55.78	13.77	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	52.87	16.27	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	48.94	10.41	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	41.30	16.52	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	49.30	12.78	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	26.65	14.31	0.37	1.36
Wilms' tumor cell line:HFWT	10597-108E3	28.16	9.68	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	58.94	11.73	0.28	0.00
achilles tendon, donor2	10292-104G4	18.60	24.80	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	34.42	12.24	0.25	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	41.33	28.79	1.39	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	67.54	26.59	2.73	3.32
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	53.33	20.41	0.54	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	53.69	26.70	0.00	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	24.74	20.51	0.85	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	29.94	7.89	0.54	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	33.49	15.86	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	42.88	25.32	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	54.36	12.43	1.16	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	46.74	16.19	0.00	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	54.61	42.91	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	37.88	22.77	1.16	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	34.69	6.47	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	36.82	11.98	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	35.32	12.55	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	39.89	18.92	2.06	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	50.03	11.97	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	54.62	18.78	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	56.41	22.75	0.30	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	60.42	26.72	0.96	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	38.53	21.61	0.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	48.36	11.01	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	7.43	1.86	1.86	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	26.37	17.70	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	37.94	13.08	0.44	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	44.99	7.50	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	93.96	18.60	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	45.45	12.72	2.48	0.78
adipose, donor1	10184-103D4	15.25	6.45	0.00	1.17
adipose, donor2	10185-103D5	8.92	4.46	1.22	1.22
adipose, donor3	10186-103D6	16.34	23.69	0.27	1.91
adipose, donor4	10187-103D7	26.00	68.47	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	38.67	4.42	0.47	0.32
adrenal gland, adult, pool1	10081-102A9	50.93	21.83	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	34.82	11.74	0.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	52.17	22.51	1.07	1.07
amniotic membrane cells, donor1	12235-129G3	36.63	8.35	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	31.44	17.92	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	29.17	11.19	0.29	0.29
amygdala - adult, donor10196	10167-103B5	21.34	7.11	0.00	0.00
amygdala, adult, donor10252	10151-102I7	102.80	14.19	0.61	0.20
amygdala, newborn, donor10223	10360-105E9	25.82	3.55	0.00	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	45.46	8.66	0.25	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	58.02	20.96	1.10	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	48.44	21.04	0.00	1.67
aorta, adult, pool1	10052-101G7	46.09	15.89	0.20	0.39
appendix, adult	10189-103D9	103.63	33.77	2.72	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	27.51	9.29	0.00	0.34
artery, adult	10190-103E1	57.06	13.59	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	27.52	19.99	0.29	0.43
b cell line:RPMI1788	10427-106D4	57.99	11.30	0.30	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	36.35	8.05	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	65.49	15.58	0.79	0.89
bile duct carcinoma cell line:TFK-1	10496-107C1	49.38	15.90	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	35.79	13.98	0.56	0.00
bladder, adult, pool1	10011-101C2	51.06	11.84	1.85	0.43
blood, adult, pool1	10053-101G8	57.58	26.58	4.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	13.70	5.99	0.00	0.00
bone marrow, adult	10192-103E3	70.86	17.55	0.67	0.67
brain, adult, donor1	10084-102B3	30.75	7.18	1.03	1.03
brain, adult, pool1	10012-101C3	25.84	11.14	0.78	1.00
brain, fetal, pool1	10085-102B4	21.37	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	63.43	20.15	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	28.96	7.24	0.12	0.12
breast, adult, donor1	10080-102A8	58.72	6.31	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	61.11	19.31	0.13	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	55.97	31.85	0.62	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	22.10	3.68	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	18.88	15.98	0.73	0.97
carcinoid cell line:NCI-H1770	10703-109H1	30.56	6.58	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	37.08	12.14	0.33	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	39.93	12.99	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	32.74	14.37	0.00	1.86
caudate nucleus - adult, donor10196	10177-103C6	18.42	5.76	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	78.14	10.54	0.50	0.50
caudate nucleus, adult, donor10258	10379-105H1	32.09	7.64	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	29.30	2.56	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	40.79	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	135.79	14.31	0.43	0.43
cerebellum, adult, pool1	10083-102B2	32.08	7.24	0.69	1.38
cerebellum, newborn, donor10223	10357-105E6	31.55	3.32	0.00	0.00
cerebral meninges, adult	10188-103D8	29.00	9.08	0.25	0.50
cerebrospinal fluid, donor2	10294-104G6	27.04	13.89	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	73.04	8.91	0.29	1.58
cervical cancer cell line:ME-180	10553-107I4	88.49	29.00	0.33	0.83
cervix, adult, pool1	10013-101C4	48.40	21.10	2.52	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	25.50	11.43	0.56	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	36.58	5.23	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	63.13	15.78	1.62	0.50
choriocarcinoma cell line:SCH	10785-110H2	44.60	9.12	0.12	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	52.65	19.45	1.19	0.00
chorionic membrane cells, donor1	12238-129G6	33.91	14.25	1.42	0.28
chorionic membrane cells, donor2	12239-129G7	55.58	12.83	2.39	0.60
chorionic membrane cells, donor3	12240-129G8	32.42	21.98	3.30	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	31.30	14.14	2.02	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	67.23	22.09	0.58	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	37.38	7.18	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	35.70	10.02	0.26	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	40.39	10.40	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	31.36	9.16	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	48.29	10.89	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	54.47	11.73	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	20.57	9.60	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	24.98	4.51	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	10.98	4.94	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	68.03	22.42	0.38	0.76
colon, adult, donor1	10082-102B1	99.96	22.61	0.00	0.00
colon, adult, pool1	10014-101C5	60.16	21.97	2.23	0.82
colon, fetal, donor1	10070-101I7	63.03	14.21	3.09	0.62
common myeloid progenitor CMP, donor1	12130-128D6	82.50	87.09	4.58	9.17
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	37.39	15.72	0.85	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	47.24	21.58	0.91	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	48.08	26.93	0.14	0.56
corpus callosum, adult, pool1	10042-101F6	57.16	19.24	1.00	2.10
cruciate ligament, donor2	10295-104G7	26.75	21.07	0.00	1.62
diaphragm, fetal, donor1	10069-101I6	65.01	14.45	0.80	0.00
diencephalon, adult	10193-103E4	23.76	7.44	1.20	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	80.36	23.42	0.00	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	55.39	15.13	0.26	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	48.14	7.46	0.00	0.00
ductus deferens, adult	10196-103E7	88.70	36.38	1.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	12.96	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	48.55	25.75	1.47	0.74
dura mater, adult, donor1	10041-101F5	39.23	27.25	1.49	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	24.87	7.77	2.44	2.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	27.37	10.03	0.72	1.29
embryonic pancreas cell line:1B2C6	10604-108F1	60.43	28.36	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	32.69	17.86	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	58.97	20.38	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	64.36	30.21	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	12.07	8.38	1.01	1.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	25.92	12.51	0.72	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	40.36	5.95	0.00	0.48
epidermoid carcinoma cell line:A431	10426-106D3	61.80	12.12	0.89	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	99.32	17.05	0.66	0.55
epididymis, adult	10197-103E8	44.58	22.61	2.09	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	21.82	7.63	0.00	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	35.78	25.17	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	108.90	23.06	0.13	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	108.85	23.42	0.89	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	110.91	22.85	0.22	0.90
esophagus, adult, pool1	10015-101C6	49.69	13.91	2.02	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	50.34	16.53	0.50	2.38
eye - muscle inferior rectus, donor1	10272-104E2	67.61	19.32	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	54.71	21.04	0.00	0.00
eye - muscle medial, donor2	10299-104H2	26.79	13.39	1.49	0.00
eye - muscle superior, donor2	10297-104G9	43.57	11.46	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	27.69	33.52	0.00	0.00
eye, fetal, donor1	10054-101G9	29.24	8.39	0.76	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	45.52	17.82	0.51	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	42.02	9.97	0.95	0.71
frontal lobe, adult, pool1	10040-101F4	34.43	12.48	0.38	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	57.65	13.21	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	32.09	10.61	0.37	0.09
gall bladder, adult	10198-103E9	62.53	24.87	1.69	0.48
gamma delta positive T cells, donor1	11937-126A2	37.04	23.08	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	29.51	17.18	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	56.18	12.67	0.84	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	46.23	18.76	0.39	0.39
gastric cancer cell line:AZ521	10549-107H9	25.09	11.31	0.16	0.16
gastric cancer cell line:GSS	10560-108A2	25.63	15.56	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	39.29	12.57	0.23	1.60
giant cell carcinoma cell line:LU65	10487-107B1	40.27	4.13	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	37.23	10.92	0.14	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	71.08	33.42	0.75	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	22.69	8.87	0.21	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	21.63	10.11	0.56	0.42
glioblastoma cell line:T98G	10485-107A8	31.24	14.68	0.44	0.33
glioma cell line:GI-1	10413-106B8	25.77	9.96	0.59	0.59
globus pallidus - adult, donor10196	10175-103C4	32.80	6.56	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	101.06	14.89	1.95	0.24
globus pallidus, adult, donor10258	10367-105F7	47.92	9.58	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	36.77	6.40	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	163.96	132.15	7.34	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	32.79	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	15.68	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	38.08	14.40	0.00	0.96
hIPS +CCl2, biol_rep1	14383-156B9	13.77	11.02	1.38	0.00
hIPS +CCl2, biol_rep2	14384-156C1	7.77	7.32	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	12.88	1.29	0.00	0.64
hIPS, biol_rep1	14380-156B6	1.44	4.31	0.00	0.00
hIPS, biol_rep2	14381-156B7	11.66	5.49	0.00	0.00
hIPS, biol_rep3	14382-156B8	11.03	8.83	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	47.41	9.77	0.00	0.57
heart - mitral valve, adult	10205-103F7	60.99	23.02	0.90	0.00
heart - pulmonic valve, adult	10206-103F8	57.52	18.04	0.26	1.05
heart - tricuspid valve, adult	10207-103F9	159.03	51.62	4.16	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	48.97	11.02	0.00	0.41
heart, adult, diseased, donor1	10051-101G6	67.71	18.74	0.00	0.43
heart, adult, pool1	10016-101C7	52.89	19.32	1.61	0.46
heart, fetal, pool1	10046-101G1	64.79	24.54	1.54	1.64
hepatic mesenchymal tumor cell line:LI90	10778-110G4	43.50	8.64	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	63.03	15.46	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	64.53	20.11	0.11	1.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	63.11	22.45	0.36	1.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	60.33	21.22	0.30	0.71
hepatoma cell line:Li-7	10484-107A7	70.62	11.57	0.22	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	66.33	12.46	0.20	0.90
hippocampus - adult, donor10196	10169-103B7	24.60	5.68	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	98.78	17.76	0.20	1.43
hippocampus, adult, donor10258	10374-105G5	10.46	2.99	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	36.66	10.93	0.70	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	19.53	1.83	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	26.90	5.11	0.00	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	18.53	4.06	0.76	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	14.66	1.69	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	12.91	4.65	0.77	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	14.05	2.28	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	11.68	4.96	1.46	2.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	20.68	5.39	0.86	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	13.35	5.42	0.42	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	8.52	6.16	0.95	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	19.13	5.63	0.32	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	7.41	0.67	0.67	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	26.13	4.85	0.16	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	21.13	4.42	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	8.73	3.49	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	24.05	8.02	0.57	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	15.70	4.80	1.74	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	14.49	7.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	9.42	2.83	0.38	3.39
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	7.73	2.27	0.00	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	7.52	1.88	0.63	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	9.47	4.25	0.16	1.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	7.26	4.94	0.87	2.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	8.67	4.48	0.30	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	24.39	5.36	0.18	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	19.40	4.56	0.00	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	17.56	4.49	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	13.38	4.22	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	17.74	5.07	0.32	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.04	6.05	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	8.27	4.14	0.00	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	6.64	3.98	0.00	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	7.95	2.05	0.51	1.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	8.44	5.11	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	12.12	3.03	0.76	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	12.43	5.04	1.01	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	24.88	6.28	1.45	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	19.61	5.79	0.00	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	17.56	5.85	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	14.67	6.42	0.61	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	0.00	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	9.93	2.65	0.33	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	10.40	2.74	1.09	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	11.94	2.90	0.72	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	10.32	2.85	0.36	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	10.74	7.16	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	9.75	3.93	0.14	1.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	7.81	3.23	0.81	1.62
immature langerhans cells, donor1	11904-125F5	14.77	7.75	0.48	0.00
immature langerhans cells, donor2	11905-125F6	38.02	21.39	0.00	0.00
insula, adult, pool1	10039-101F3	43.44	16.66	0.66	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	74.46	29.59	0.65	0.33
kidney, adult, pool1	10017-101C8	56.67	23.43	0.90	1.10
kidney, fetal, pool1	10045-101F9	48.31	14.01	0.99	1.98
large cell lung carcinoma cell line:IA-LM	10509-107D5	35.08	17.47	0.14	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	32.76	12.44	0.69	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	70.65	6.24	0.00	0.37
left atrium, adult, donor1	10079-102A7	35.96	20.70	1.09	0.00
left ventricle, adult, donor1	10078-102A6	62.20	17.19	1.52	0.00
leiomyoblastoma cell line:G-402	10721-110A1	46.24	13.68	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	22.99	4.67	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	26.63	7.61	0.00	0.54
leiomyoma cell line:15425	10571-108B4	38.85	6.07	0.49	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	40.78	6.27	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	38.61	11.57	0.35	0.00
liposarcoma cell line:KMLS-1	10782-110G8	28.43	17.65	0.47	0.31
liposarcoma cell line:SW 872	10726-110A6	52.15	15.60	0.97	0.49
liver, adult, pool1	10018-101C9	66.61	26.25	4.05	0.32
liver, fetal, pool1	10086-102B5	56.44	15.05	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	47.25	9.04	0.29	0.87
locus coeruleus, adult, donor10252	10165-103B3	64.41	9.78	0.37	0.37
locus coeruleus, adult, donor10258	10375-105G6	27.09	6.77	0.00	0.85
locus coeruleus, newborn, donor10223	10362-105F2	32.39	5.47	1.26	0.42
lung adenocarcinoma cell line:A549	10499-107C4	19.51	9.41	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	39.99	4.14	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	41.65	36.25	0.92	0.26
lung, adult, pool1	10019-101D1	48.55	12.99	2.60	0.59
lung, fetal, donor1	10068-101I5	29.97	13.98	0.86	0.57
lung, right lower lobe, adult, donor1	10075-102A3	88.89	23.83	3.67	1.83
lymph node, adult, donor1	10077-102A5	53.96	19.41	1.89	0.95
lymphangiectasia cell line:DS-1	10727-110A7	51.29	8.77	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	32.15	26.11	1.36	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	61.16	18.69	0.85	0.00
mature adipocyte, donor1	12231-129F8	33.30	15.54	1.33	0.44
mature adipocyte, donor2	12232-129F9	40.26	13.07	0.42	0.00
mature adipocyte, donor3	12233-129G1	30.82	17.07	1.66	0.24
mature adipocyte, donor4	12234-129G2	32.11	11.58	1.05	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	50.99	14.06	0.24	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	27.07	5.64	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	80.55	11.40	0.18	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	20.01	5.08	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	22.18	7.68	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	30.71	6.08	0.17	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	101.23	14.43	0.42	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	3.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	22.61	5.74	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	27.26	7.79	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	99.85	14.86	0.15	0.46
medulla oblongata, adult, pool1	10038-101F2	41.30	13.14	0.49	1.55
medulla oblongata, newborn, donor10223	10361-105F1	37.50	6.25	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	47.82	21.26	0.66	1.11
medulloblastoma cell line:ONS-76	10759-110E3	62.36	13.69	0.12	0.24
melanoma cell line:COLO 679	10514-107E1	25.73	17.97	1.29	0.86
melanoma cell line:G-361	10465-106H6	44.79	27.96	2.99	0.81
meningioma cell line:HKBMM	10691-109F7	45.05	9.95	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	51.99	37.01	1.76	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	57.55	17.89	0.26	2.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	34.68	16.42	0.31	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	28.18	12.91	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	27.74	12.84	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	23.60	7.02	0.00	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	25.61	7.90	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	26.37	13.88	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	19.91	8.07	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	26.91	11.27	0.58	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	27.46	9.42	0.27	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	31.33	9.99	0.54	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	42.96	7.97	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	21.41	5.93	0.00	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	33.62	12.59	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	40.49	12.22	1.05	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	28.38	5.92	0.20	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	21.93	8.27	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	23.90	8.79	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	29.64	3.65	0.46	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	22.66	15.94	0.00	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	22.12	9.71	0.00	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	38.51	10.15	0.35	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	26.51	6.26	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	32.34	10.02	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	31.16	17.26	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	23.29	10.05	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	23.28	11.25	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	28.27	12.04	1.83	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.65	11.40	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	24.24	9.18	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	26.74	11.51	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	26.33	12.18	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	15.76	8.34	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	29.13	13.84	0.58	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	28.56	12.27	1.12	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	26.92	9.37	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	25.67	13.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	21.48	11.75	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	25.38	7.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	25.34	10.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	16.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	23.06	7.79	0.32	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	5.82	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	21.32	7.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.08	9.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	29.15	10.50	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	10.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	20.86	4.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	18.97	7.12	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	28.02	2.44	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	28.50	7.60	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	23.80	10.35	1.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	23.64	8.60	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	6.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	22.82	8.56	0.81	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	29.39	11.12	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	29.48	5.90	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	26.49	7.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	24.06	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	31.93	16.56	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	15.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.72	17.90	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	24.74	7.42	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	17.94	8.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	23.53	7.63	1.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	19.75	6.85	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	10.90	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	13.94	10.14	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.24	12.74	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	27.11	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	16.47	11.53	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	15.28	1.59	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	20.77	11.36	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	19.35	11.20	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.08	10.06	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	34.49	5.91	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	22.94	13.21	0.93	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	59.83	21.37	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	35.24	14.39	0.31	0.00
mesothelioma cell line:Mero-25	10850-111F4	42.44	12.71	0.91	1.13
mesothelioma cell line:Mero-41	10851-111F5	51.10	24.45	0.73	0.49
mesothelioma cell line:Mero-48a	10852-111F6	31.89	12.18	0.22	0.44
mesothelioma cell line:Mero-82	10853-111F7	53.88	32.06	1.31	1.05
mesothelioma cell line:Mero-83	10854-111F8	60.26	17.02	0.17	0.17
mesothelioma cell line:Mero-84	10855-111F9	44.99	12.39	0.51	0.25
mesothelioma cell line:Mero-95	10856-111G1	45.55	14.91	0.41	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	52.34	23.52	0.99	0.17
mesothelioma cell line:NCI-H226	10846-111E9	28.60	14.30	0.72	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	20.84	16.06	0.85	0.51
mesothelioma cell line:NCI-H28	10845-111E8	41.48	39.70	0.51	0.25
mesothelioma cell line:No36	10857-111G2	41.75	15.33	0.65	0.65
mesothelioma cell line:ONE58	10858-111G3	48.50	15.17	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	20.73	2.49	0.38	0.00
migratory langerhans cells, donor2	11902-125F3	32.60	6.23	0.37	0.00
migratory langerhans cells, donor3	11903-125F4	29.97	3.95	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	59.09	7.51	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	23.95	5.93	0.21	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	49.07	12.67	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	36.54	17.89	0.57	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	40.47	14.78	0.00	0.00
myeloma cell line:PCM6	10474-106I6	55.94	27.67	1.19	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	44.64	19.28	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	30.01	40.60	0.98	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	35.99	6.02	0.22	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	28.97	4.49	0.29	0.15
nasal epithelial cells, donor2	12227-129F4	35.33	29.81	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	10.35	7.13	0.46	2.07
neuroblastoma cell line:NB-1	10539-107G8	39.48	10.85	0.56	1.87
neuroblastoma cell line:NBsusSR	10607-108F4	19.19	6.12	0.21	0.63
neuroblastoma cell line:NH-12	10555-107I6	39.88	17.33	0.19	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	35.35	7.59	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	33.74	12.35	0.32	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	14.29	8.25	0.60	1.61
neuroepithelioma cell line:SK-N-MC	10728-110A8	20.34	3.81	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	58.56	18.10	0.27	0.53
neutrophil PMN, donor1	12133-128D9	59.50	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	58.85	22.15	1.35	4.23
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	27.22	8.81	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	24.05	7.05	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	32.06	11.04	1.58	0.00
nucleus accumbens, adult, pool1	10037-101F1	43.03	11.34	0.00	1.22
occipital cortex - adult, donor10196	10172-103C1	28.85	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	115.66	13.42	0.00	0.54
occipital cortex, newborn, donor10223	10355-105E4	33.85	5.10	0.00	0.73
occipital lobe, adult, donor1	10076-102A4	41.46	9.71	0.79	1.57
occipital lobe, fetal, donor1	10073-102A1	35.62	8.15	0.00	1.29
occipital pole, adult, pool1	10036-101E9	30.91	9.07	0.24	0.79
olfactory region, adult	10195-103E6	37.26	11.08	0.38	0.19
optic nerve, donor1	10277-104E7	64.03	36.02	4.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	178.04	38.16	2.16	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	80.92	15.66	0.41	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	50.29	10.67	0.17	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	53.37	46.43	1.27	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	37.63	17.05	0.88	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	20.56	12.15	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	27.78	10.82	1.27	0.64
ovary, adult, pool1	10020-101D2	42.98	14.06	2.01	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	39.41	1.83	0.18	0.18
pancreas, adult, donor1	10049-101G4	79.01	35.74	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	84.70	45.56	0.84	1.40
papillary adenocarcinoma cell line:8505C	10437-106E5	64.39	19.08	0.51	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	48.85	18.88	1.16	0.00
paracentral gyrus, adult, pool1	10035-101E8	38.90	11.35	0.37	0.82
parietal cortex, adult, donor10258	10373-105G4	15.41	13.95	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	19.75	6.58	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	80.10	6.84	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	38.68	10.31	0.26	0.70
parietal lobe, fetal, donor1	10072-101I9	27.16	4.85	0.00	2.91
parietal lobe, newborn, donor10223	10356-105E5	28.79	3.74	0.00	0.00
parotid gland, adult	10199-103F1	66.60	17.88	0.62	0.00
penis, adult	10200-103F2	53.17	30.08	0.54	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	49.46	4.65	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	82.46	18.94	1.02	0.58
pineal gland - adult, donor10196	10179-103C8	45.80	19.35	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	68.10	17.77	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	25.08	15.05	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	46.54	29.34	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	97.46	30.75	1.04	1.04
pituitary gland, adult, donor10258	10378-105G9	45.97	18.73	1.70	0.85
placenta, adult, pool1	10021-101D3	54.72	29.78	1.08	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	55.22	14.70	0.26	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	32.22	17.43	0.78	0.47
pons, adult, pool1	10033-101E6	26.85	9.04	0.00	0.69
postcentral gyrus, adult, pool1	10032-101E5	31.38	11.07	0.17	0.87
promyelocytes/myelocytes PMC, donor1	12132-128D8	148.49	62.74	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	22.03	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	35.21	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	49.09	23.31	1.60	0.44
prostate cancer cell line:PC-3	10439-106E7	46.65	11.80	0.00	0.18
prostate, adult, pool1	10022-101D4	49.34	17.14	1.54	0.63
putamen, adult, donor10196	10176-103C5	61.14	10.86	0.00	0.47
putamen, adult, donor10252	10152-102I8	41.18	5.88	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	3.28	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	26.34	7.73	0.24	0.48
putamen, newborn, donor10223	10365-105F5	26.24	3.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	36.95	6.69	0.00	0.00
rectum, fetal, donor1	10067-101I4	31.99	8.35	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	32.65	8.27	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.20	2.49	0.00	0.00
retina, adult, pool1	10030-101E3	46.82	27.83	1.09	0.89
retinoblastoma cell line:Y79	10475-106I7	15.33	7.01	1.04	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	50.29	12.54	0.61	1.11
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	20.81	11.81	0.56	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	40.92	12.88	0.00	0.00
salivary acinar cells, donor1	11771-123I7	44.67	16.51	0.49	0.32
salivary acinar cells, donor2	11772-123I8	45.30	18.86	0.96	0.41
salivary acinar cells, donor3	11773-123I9	49.65	13.24	0.00	0.00
salivary gland, adult, pool1	10093-102C3	43.47	14.87	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	35.07	6.32	0.00	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	29.51	6.11	0.35	0.47
seminal vesicle, adult	10201-103F3	66.66	21.69	3.17	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	38.87	20.89	0.00	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	22.65	7.30	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	43.15	14.05	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	64.61	14.10	0.27	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	49.18	7.96	0.99	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	29.16	28.64	1.29	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	66.68	15.61	0.71	1.42
skeletal muscle, adult, pool1	10023-101D5	64.17	17.15	3.96	1.08
skeletal muscle, fetal, donor1	10066-101I3	14.07	6.03	0.00	0.00
skin, adult, donor1	10074-102A2	61.07	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	63.12	14.52	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	96.72	17.68	1.00	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	31.84	18.28	0.63	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	17.35	8.29	0.19	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	41.37	22.75	0.49	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	27.34	3.38	0.00	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	35.30	27.02	1.09	0.22
small intestine, adult, pool1	10024-101D6	77.52	30.22	2.75	1.31
small intestine, fetal, donor1	10064-101I1	47.67	14.50	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	45.14	15.90	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	59.96	16.02	1.29	0.26
somatostatinoma cell line:QGP-1	10781-110G7	72.90	21.17	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	46.80	7.11	0.23	1.38
spinal cord, adult, donor10252	10159-103A6	48.10	8.67	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	5.53	2.77	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	46.35	14.64	1.83	1.22
spinal cord, newborn, donor10223	10359-105E8	36.28	7.81	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	58.25	15.68	0.15	0.30
spleen, adult, pool1	10025-101D7	58.92	18.94	1.43	0.44
spleen, fetal, pool1	10044-101F8	53.47	18.04	0.72	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	45.55	9.83	0.31	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	33.99	9.11	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	48.57	9.78	0.70	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	91.48	12.12	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	71.70	9.57	0.34	1.24
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	47.87	10.59	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	38.50	20.73	0.42	0.42
stomach, fetal, donor1	10062-101H8	70.49	24.56	0.00	1.07
submaxillary gland, adult	10202-103F4	60.39	17.66	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	73.94	15.37	0.42	0.21
substantia nigra, adult, donor10258	10371-105G2	9.83	4.66	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	38.86	3.53	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	36.45	14.90	1.38	0.92
temporal lobe, adult, pool1	10031-101E4	37.47	11.53	0.59	0.85
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	21.37	2.14	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	20.22	6.15	0.00	1.32
tenocyte, donor1	11763-123H8	57.95	23.74	0.70	0.70
tenocyte, donor2	11765-123I1	37.77	11.06	0.76	0.00
tenocyte, donor3	11768-123I4	50.41	14.83	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	28.55	6.46	0.00	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	33.76	20.35	0.31	0.92
teratocarcinoma cell line:PA-1	10807-111A6	21.08	6.51	0.15	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	43.80	8.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	24.20	6.05	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	32.50	5.89	0.55	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	57.65	5.54	0.00	0.65
testis, adult, pool1	10026-101D8	24.91	11.49	4.08	0.43
testis, adult, pool2	10096-102C6	28.87	20.30	0.00	0.00
thalamus - adult, donor10196	10168-103B6	15.46	5.52	0.00	0.00
thalamus, adult, donor10252	10154-103A1	80.80	10.00	0.63	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	20.09	4.61	0.16	0.66
thalamus, newborn, donor10223	10366-105F6	17.26	4.03	0.00	0.00
throat, adult	10209-103G2	57.42	17.23	3.25	0.75
throat, fetal, donor1	10061-101H7	43.57	9.75	0.00	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	64.39	13.71	0.60	1.39
thymus, adult, pool1	10027-101D9	57.46	14.22	3.68	1.89
thymus, fetal, pool1	10043-101F7	60.68	12.16	1.97	1.45
thyroid carcinoma cell line:KHM-5M	10776-110G2	37.49	9.84	0.53	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	114.97	19.00	1.12	0.84
thyroid, adult, pool1	10028-101E1	53.10	19.50	1.59	0.47
thyroid, fetal, donor1	10060-101H6	69.08	29.00	0.26	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	18.48	0.00	0.00
tongue, adult	10203-103F5	53.96	22.56	1.86	0.70
tongue, fetal, donor1	10059-101H5	55.96	13.40	0.79	1.18
tonsil, adult, pool1	10047-101G2	57.00	22.94	0.90	0.90
trachea, adult, pool1	10029-101E2	59.88	19.39	1.15	0.82
trachea, fetal, donor1	10058-101H4	56.17	10.39	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	37.91	16.30	0.00	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	40.12	15.50	0.30	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	43.72	15.83	0.47	0.78
tridermal teratoma cell line:HGRT	10694-109G1	45.66	7.61	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	50.96	26.83	0.85	0.51
umbilical cord, fetal, donor1	10057-101H3	41.73	10.43	0.00	0.00
uterus, adult, pool1	10100-102D1	40.10	13.82	0.34	0.51
uterus, fetal, donor1	10055-101H1	40.44	10.75	0.00	1.02
vagina, adult	10204-103F6	99.51	9.05	2.58	0.00
vein, adult	10191-103E2	52.39	14.91	1.53	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	25.37	7.48	0.27	0.27